Geneeskunde voor het Volk-Genk ASBL

14.9 FTE

Geneeskunde voor het Volk-Genk reported revenue of €1.17m for the 2025 financial year (annual accounts filed with the NBB on 04 Jun 2026), with 14.9 full-time equivalents.

By total assets for 2025, Geneeskunde voor het Volk-Genk ranks among the 2,000 largest of the 9,914 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0418.710.990 · VAT BE0418710990
3600 Genk
active in General medical practice activities (NACE 86210)
operating since 01 Jun 1978 (≈ 48 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Geneeskunde voor het Volk-Genk shows with a free account.

See the score
Profile
ASBL Small · 14.9 FTE since 1978
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€1.17m
Net result170,518 €
Equity769,320 €
Cash629,154 €
EBITDA216,567 €
Total assets902,922 €
Headcount (avg FTE)14.9
The line marks its sector median: 72.4% (5478 companies).

Change 2022 → 2025: Equity +38 % Total assets +17 % Headcount (avg FTE) +6 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Geneeskunde voor het Volk-Genk's annual accounts

20252024202320222021
Revenue€1.17m
Net result170,518 €
Equity769,320 €
Cash629,154 €
EBITDA216,567 €
Total assets902,922 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 04 Jun 2026
  • Year ended 31 Dec 2024filed on 24 Jun 2025
  • Year ended 31 Dec 2023filed on 30 Jul 2024
  • Year ended 31 Dec 2022filed on 28 Aug 2023
  • Year ended 31 Dec 2021filed on 09 May 2023

Geneeskunde voor het Volk-Genk's financial analysis

Management and control of Geneeskunde voor het Volk-Genk

2 active director(s) in the register.

Geneeskunde voor het Volk-Genk's shareholders and holdings →

Geneeskunde voor het Volk-Genk's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0418.710.990
VAT number
BE0418710990
Peppol
Registered · 0208:0418710990 · as of 10 Nov 2026
Legal form
ASBL
Incorporated
01 Jun 1978
Registered office
3600 Genk
Size
Small · 14.9 FTE
Latest accounts
2025 · filed on 04 Jun 2026
Activity
General medical practice activities (NACE 86210)

Geneeskunde voor het Volk-Genk (ASBL) has been based in Genk since 1978, active in: general medical practice activities. For 2025, it reports revenue of €1.17m, a net profit of 170,518 € and equity of 769,320 €. With 14.9 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 85.2%, above the median of its sector (72.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Geneeskunde voor het Volk-Genk

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Geneeskunde voor het Volk-Genk

What is the revenue of Geneeskunde voor het Volk-Genk?

According to the 2025 annual accounts filed with the NBB, the revenue of Geneeskunde voor het Volk-Genk amounts to 1,167,723 €.

What is the VAT number of Geneeskunde voor het Volk-Genk?

In Belgium, the VAT number is the company number prefixed with BE: BE0418710990 for Geneeskunde voor het Volk-Genk, if the company is VAT-registered. Its company number (CBE) is 0418.710.990.

Where is the registered office of Geneeskunde voor het Volk-Genk?

According to the CBE register, the registered office of Geneeskunde voor het Volk-Genk is in 3600 Genk.

What is the equity of Geneeskunde voor het Volk-Genk?

At the close of the 2025 financial year, the equity of Geneeskunde voor het Volk-Genk amounts to 769,320 €, a solvency of 85.2% of total assets.

How many people work at Geneeskunde voor het Volk-Genk?

14.9 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Geneeskunde voor het Volk-Genk?

The register lists 2 active mandates at Geneeskunde voor het Volk-Genk. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Geneeskunde voor het Volk-Genk within its sector?

By total assets for 2025, Geneeskunde voor het Volk-Genk ranks among the 2,000 largest of the 9,914 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year.

Idonis

The full file of Geneeskunde voor het Volk-Genk

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 22 Jul 2026

No credit card, no commitment.

What each plan unlocks →